ABSTRACT
This chapter assesses the regulatory initiatives that have taken place in the United Kingdom since the publication of the reports by the Nuffield Council and the Advisory Group on the Ethics of Xenotransplantation. It considers the ways in which United Kingdom Xenotransplantation Interim Regulatory Authority has sought to fulfil its regulatory role. The chapter shows that efforts to regulate biotechnology procedures like animal to human transplantation must test not only what is possible, but also what is ethically acceptable and legally permissible. It should be noted that UlOCIRA gains information on developments in xenotransplantation by liaising with representatives of the industries it regulates and various international organizations. To specify the biosecurity conditions for each stage in the xenotransplantation procedure which minimise the risks to human health from infections and other disorders resulting from the handling of source animals or as a consequence of the transplantation process.
